MT 6345
/ Mitsubishi Tanabe
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 11, 2020
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-6345 in Healthy Subjects
(clinicaltrials.gov)
- P1; N=52; Terminated; Sponsor: Mitsubishi Tanabe Pharma Development America, Inc.; N=120 ➔ 52; Recruiting ➔ Terminated; Preclinical finding
Clinical • Enrollment change • Trial termination
1 to 1
Of
1
Go to page
1